The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Belova A.N.

Privolzhsky Research Medical University

Grygorieva V.N.

Privolzhsky Research Medical University

Rasteryaeva M.V.

Privolzhsky Research Medical University

Ruina E.A.

Privolzhsky Research Medical University

Belova E.M.

City Clinical Hospital No. 3

Solovieva V.S.

City Clinical Hospital No. 3

Boyko A.N.

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Anti-NMDAR encephalitis associated with relapsing optic neuritis

Authors:

Belova A.N., Grygorieva V.N., Rasteryaeva M.V., Ruina E.A., Belova E.M., Solovieva V.S., Boyko A.N.

More about the authors

Read: 3669 times


To cite this article:

Belova AN, Grygorieva VN, Rasteryaeva MV, Ruina EA, Belova EM, Solovieva VS, Boyko AN. Anti-NMDAR encephalitis associated with relapsing optic neuritis. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(6):105‑113. (In Russ.)
https://doi.org/10.17116/jnevro2020120061105

Recommended articles:
Surgical treatment of seco­ndary trigeminal neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):203-209
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40
Subjective sleep quality evaluation in patients with neuromyelitis optica spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):57-61
A portrait of a doctor with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):160-164
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Epidemiology of multiple scle­rosis in the city of Novo­sibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21

References:

  1. Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Annals of Neurology. 2005;58(4):594-604.  https://doi.org/10.1002/ana.20614
  2. Dalmau J, Tüzün E, Wu H, Masjuan J, Rossi J, Voloschin A, Baehring J, Shimazaki H, Koide R, King D, Mason W, Sansing L, Dichter M, Rosenfeld M, Lynch D. Paraneoplastic anti- N -methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Annals of Neurology. 2007;61(1):25-36.  https://doi.org/10.1002/ana.21050
  3. Graus F, Titulaer MJ, Balu R, Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391-404.  https://doi.org/10.1016/S1474-4422(15)00401-9
  4. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63-74.  https://doi.org/10.1016/S1474-4422(10)70253-2
  5. Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch D, Suzuki N, Hata T, Dalmau J. Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal. Neurology. 2008;70(7):504-511. 
  6. Tuzune E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007;13(5):261-271. 
  7. Gastaldi M, Nosadini M, Spatola M, Sartori S, Franciotta D. N-methyl-D-aspartate receptor encephalitis: laboratory diagnostics and comparative clinical features in adults and children. Expert Rev Mol Diagn. 2018;18(2):181-193.  https://doi.org/10.1080/14737159.2018.1431124
  8. Guasp M, Dalmau J. Encephalitis associated with antibodies against the NMDA receptor. Med Clin (Barc). 2018;151(2):71-79.  https://doi.org/10.1016/j.medcli.2017.10.015
  9. Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, Yamamoto T, Reindl M, Rosenfeld MR, Graus F, Saiz A, Dalmau J. Overlapping demyelinating syndromes and anti-N-methyl-d-aspartate receptor encephalitis. Ann Neurol. 2014;75(3):411-428. 
  10. Zoccarato M, Saddi MV, Serra G, Pelizza MF, Rosellini I, Peddone L, Ticca A, Giometto B, Zuliani L. Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis. J Neurol. 2013;260(12):3185-3187. https://doi.org/10.1007/s00415-013-7182-x
  11. Fan S, Xu Y, Ren H, Guan H, Feng F, Gao X, Ding D, Fang F, Shan G, Guan T, Zhang Y, Dai Y, Yao M, Peng B, Zhu Y, Cui L. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis. Mult Scler Relat Disord. 2018;20:144-152.  https://doi.org/10.1016/j.msard.2018.01.007
  12. Vasenina EE, Levin OS, Gan’kina OA, Chimagomedova AS, Levikov DI. Autoimmune anti-NMDA-R encephalitis. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117(2):111-116. (In Russ.). https://doi.org/10.17116/jnevro201711721110-116
  13. Davydovskaya MV, Boyko AN, Beliaeva IA, Martynov MY, Gusev EI. Autoimmune encephalitis. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2015;115(4):95-101. (In Russ.). https://doi.org/10.17116/jnevro20151154195-101
  14. Liu CY, Zhu J, Zheng XY, Ma C, Wang X. Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis. Mediators Inflamm. 2017;6361479. https://doi.org/10.1155/2017/6361479
  15. Inayat F, Hung Pinto WA, Ahmad S, Hussain A, Ullah W. Anti-N-methyl-D-aspartate Receptor Encephalitis Associated with Ictal Torsades de Pointes and Cardiac Arrest. Cureus. 2019;11(6):e4837. https://doi.org/10.7759/cureus.4837
  16. Lynch DR, Anegawa NJ, Verdoorn T, Pritchett DB. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents. Molecular Pharmacology. 1994;45(3):540-545. 
  17. Paoletti P, Bellone C, Zhou O. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci. 2013;14(6):383-400. 
  18. Lipton SA. NMDA receptors, glial cells, and clinical medicine. Neuron. 2006;50:9-11. 
  19. Tüzün E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol. 2009;118:737-743. 
  20. Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology. 2011;77(6):589-593.  https://doi.org/10.1212/WNL.0b013e318228c136
  21. Li C, Xiao L, Liu X, Yang W, Shen W, Hu C, Yang G, He C. A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination. Glia. 2013;61(5):732-749.  https://doi.org/10.1002/glia.22469
  22. Miya K, Takahashi Y, Mori H. Anti-NMDAR autoimmune encephalitis. Brain Dev. 2014;36:645-652.  https://doi.org/10.1016/j.braindev.2013.10.005
  23. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091-1098. https://doi.org/10.1016/S1474-4422(08)70224-2
  24. Moscato EH, Peng X, Jain A, Parsons TD, Dalmau J, Balice-Gordon RJ. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Annals of Neurology. 2014;76(1):108-119.  https://doi.org/10.1002/ana.24195
  25. Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, Parsons TD, Lynch DR, Dalmau J, Balice-Gordon RJ. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. The Journal of Neuroscience. 2010;30(17):5866-5875. https://doi.org/10.1523/JNEUROSCI.0167-10.2010
  26. Zandi M, Irani S, Follows G, Moody A, Molyneux P, Vincent A. Limbic encephalitis associated with antibodies to the NMDA receptor in hodgkin lymphoma. Neurology. 2009;73(23):2039-2040. https://doi.org/10.1212/wnl.0b013e3181c55e9b
  27. Lebas A, Husson B, Didelot A, Honnorat J, Tardieu M. Expanding Spectrum of Encephalitis With NMDA Receptor Antibodies in Young Children. Journal of Child Neurology. 2009;25(6):742-745.  https://doi.org/10.1177/0883073809343319
  28. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157-165.  https://doi.org/10.1016/S1474-4422(12)70310-1
  29. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A. N-methyl-D-aspartate antibody encephalitis:temporal progression of clinical and paraclinical observations in a predominantly non-paraneop lastic disorder of both sexes. Brain. 2010;133:1655-1667. https://doi.org/10.1093/brain/awq113
  30. Desena D Graves, Warnack W, Greenberg BM. Herpes simplex encephalitis as a potential cause of anti-N-methyl-D-aspartate receptor antibody encephalitis: report of 2 cases. JAMA Neurology. 2014;71(3):344-346. 
  31. Ma C, Wang C, Zhang Q, Lian Y. Emerging role of prodromal headache in patients with anti-N-methyl-D-aspartate receptor encephalitis. J Pain Res. 2019;30(12):519-526.  https://doi.org/10.2147/JPR.S189301
  32. Peery HE, Gregory S. Day, Anti-NMDA receptor encephalitis. The disorder,the diagnosis and the immunobiology. Autoimmun Rev. 2012;11:863-872.  https://doi.org/10.1016/j.autrev.2012.03.001
  33. Qin K, Wu W, Huang Y, Xu D, Zhang L, Zheng B, Jiang M, Kou C, Gao J, Li W, Zhang J, Wang S, Luan Y, Yan C, Xu D, Zheng X. Anti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilis. BMC Neurol. 2017;17:1. Published online 2017 Jan 5.  https://doi.org/10.1186/s12883-016-0787-9
  34. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J. Anti-N-methyl-D-aspartate receptor(NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66:11-18.  https://doi.org/10.1002/ana.21756
  35. Gabilondo I, Saiz A, Galán L, González V, Jadraque R, Sabater L, Sans A, Sempere A, Vela A, Villalobos F, Viñals M, Villoslada P, Graus F. Analysis of relapses in anti-NMDAR encephalitis. Neurology. 2011;77(10):996-999.  https://doi.org/10.1212/WNL.0b013e31822cfc6b
  36. Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch D, Graus F, Dalmau. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167-177.  https://doi.org/10.1016/S1474-4422(13)70282-5
  37. Viaccoz A, Desestret V, Ducray F, Picard G, Cavillon G, Rogemond V, Antoine JC, Delattre JY, Honnorat J. Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology. 2014;82:556-563.  https://doi.org/10.1212/WNL.0000000000000126
  38. Zandi MS, Paterson RW, Ellul MA, Jacobson L, Al-Diwani A, Jones JL, Cox AL, Lennox B, Stamelou M, Bhatia KP, Schott JM, Coles AJ, Kullmann DM, Vincent A. Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes. J Neurol Neurosurg Psychiatry. 2015;86:708-713.  https://doi.org/10.1136/jnnp-2014-308736
  39. Wang R, Guan HZ, Ren HT, Wang W, Hong Z, Zhou D. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis. Seizure. 2015;29:137-142.  https://doi.org/10.1016/j.seizure.2015.04.005
  40. Waschbisch A, Kallmünzer B, Schwab S, Gölitz P, Vincent A, Lee D-H, Linker RA. Demyelinating disease and anti-N-methyl-D-aspartate receptor immunoglobulin G antibodies: a case report. BMC Research Notes. 2015;7:948.  https://www.biomedcentral.com/1756-0500/7/948
  41. Dahm L, Ott C, Steiner J, Stepniak B, Teegen B, Saschenbrecker S, Hammer C, Borowski K, Begemann M, Lemke S, Rentzsch K, Probst C, Martens H, Wienands J, Spalletta G, Weissenborn K, Stocker W, Ehrenreich H: Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol. 2014;76:82-94.  https://doi.org/10.1002/ana.24189
  42. Ishikawa N, Tajima G, Hyodo S, Takahashi Y, Kobayashi M. Detection of autoantibodies against NMDA-type glutamate Receptor in a patient with recurrent optic neuritis and transient cerebral lesions. Neuropediatrics. 2007;38(5):257-260.  https://doi.org/10.1055/s-2007-1004521
  43. Tao S, Zhang Y, Ye H, Guo D. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review. Mult Scler Relat Disord. 2019;20(35):185-192.  https://doi.org/10.1016/j.msard.2019.07.008
  44. Ran Y, Wang L, Zhang F, Ao R, Dong Z, Yu S. Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: A case report and literature review. Clin Neurol Neurosurg. 2017;155:75-82.  https://doi.org/10.1016/j.clineuro.2017.02.016
  45. Takeda A, Shimada H, Tamura A, Yasui M, Yamamoto K, Itoh K, Ataka S, Tanaka S, Ohsawa M, Hatsuta H, Hirano M, Sakamoto H, Ueno S, Nakamura Y, Tsutada T, Miki T. A case of anti-N-methyl-D-aspartate receptor encephalitis with multiple sclerosis-like demyelinated lesions. Multiple Sclerosis and Related Disorders. 2014;3(3):391-397.  https://doi.org/10.1016/j.msard.2013.09.005
  46. Luo JJ, Lv H, Sun W, Zhao J, Hao HJ, Gao F, Huang YN. Anti-N-methyl-d-aspartate receptor encephalitis in a patient with neuromyelitis optica spectrum disorders. Mult Scler Relat Disord. 2016;8:74-77.  https://doi.org/10.1016/j.msard.2016.05.002
  47. Hacohen Y, Absoud M, Hemingway C, Jacobson L, Lin JP, Pike M, Pullaperuma S, Siddiqui A, Wassmer E, Waters P, Irani SR, Buckley C, Vincent A, Lim M. NMDA receptor antibodies associated with distinct white matter syndromes. Neurol Neuroimmunol Neuroinflamm. 2014;24;1(1):e2.  https://doi.org/10.1212/NXI.0000000000000002
  48. Kaneko K, Sato DK, Misu T, Kurosawa K, Nakashima I, Fujihara K, Aoki M.2014. Anti-N-methyl-D-aspartate receptor encephalitis with multiphasic demyelination. Ann Neurol. 2014;76(3):462-464.  https://doi.org/10.1002/ana.24224
  49. Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG; International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177-189.  https://doi.org/10.1212/WNL.0000000000001729
  50. Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014;176(2):149-164.  https://doi.org/10.1111/cei.12271
  51. Kruer MC, Koch TK, Bourdette DN. NMDA receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology. 2010;74(18):1473-1475. https://doi.org/10.1212/WNL.0b013e3181dc1a7f
  52. Jurynczyk M, Geraldes R, Probert F, Woodhall MR, Waters P, Tackley G, DeLuca G, Chandratre S, Leite MI, Vincent A, Palace J. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis. Brain. 2017;140(3):617-627.  https://doi.org/10.1093/brain/aww350
  53. Ishiura H, Matsuda S, Higashihara M, Hasegawa M, Hida A, Hanajima R, Yamamoto T, Shimizu J, Dalmau J, Tsuji S. Response of anti-NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology. 2008;71(23):1921-1923. https://doi.org/10.1212/01.wnl.0000336648.43562.59
  54. Kadoya M, Onoue H, Kadoya A, Ikewaki K, Kaida K. Refractory status epilepticus caused by anti-NMDA receptor encephalitis that markedly improved following combination therapy with rituximab and cyclophosphamide. Internal Medicine. 2015;54(2):209-213.  https://doi.org/10.2169/internalmedicine.54.2047
  55. Wang K, Chen Z, Wu D, Ding Q, Zheng X, Wang J, Ji C, Luo B. Early second-line therapy is associated with improved episodic memory in anti-NMDA receptor encephalitis. Ann Clin Transl Neurol. 2019;6(7):1202-1213. https://doi.org/10.1002/acn3.50798
  56. Casares M, Skinner HJ, Gireesh ED, Wombles C, Schweitzer J, Gwyn PG, Newton HB, Makar SM, Lee K, Westerveld M. Successful Intrathecal Rituximab Administration in Refractory Nonteratoma Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report. J Neurosci Nurs. 2019;51(4):194-197.  https://doi.org/10.1097/JNN.0000000000000450
  57. Masghati S, Nosratian M, Dorigo O. Anti-N-methyl-aspartate receptor encephalitis in identical twin sisters: role for oophorectomy. Obstetrics and Gynecology. 2014;123(2):433-435. 
  58. Malter MP, Frisch C, Schoene-Bake JC, Helmstaedter C, Wandinger KP, Stoecker W, Urbach H, Surges R, Elger CE, Vincent AV, Bien CG. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol. 2014;261(9):1695-1705. https://doi.org/10.1007/s00415-014-7408-6
  59. Lim JA, Lee ST, Jung KH, Kim S, Shin JW, Moon J, Byun JI, Kim TJ, Shin YW, Lee KJ, Kim YS, Park KI, Lee SK, Chu K. Anti-N-methyl-D-aspartate receptor encephalitis in Korea: clinical features, treatment, and outcome. Journal of Clinical Neurophysiology. 2014;10(2):157-161.  https://doi.org/10.3988/jcn.2014.10.2.157

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.